Karyopharm reports strong fourth quarter and full year 2021 financial results and highlights recent company progress

Newton, mass., feb. 8, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti) ("karyopharm," the "company," "we" and "our"), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the fourth quarter and full year ended december 31, 2021.

KPTI Ratings Summary

KPTI Quant Ranking